These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7737583)

  • 1. HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: integration between virus and immune system.
    Garzetti GG; Ciavattini A; Goteri G; De Nictolis M; Menso S; Muzzioli M; Fabris N
    Gynecol Obstet Invest; 1995; 39(2):130-5. PubMed ID: 7737583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status.
    Garzetti GG; Ciavattini A; Butini L; Vecchi A; Montroni M
    Gynecol Obstet Invest; 1995; 40(1):52-6. PubMed ID: 7557645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
    Nagai N
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
    Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
    J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals.
    Luxton JC; Rowe AJ; Cridland JC; Coletart T; Wilson P; Shepherd PS
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1585-93. PubMed ID: 8758003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring.
    Cuschieri KS; Whitley MJ; Cubie HA
    J Med Virol; 2004 May; 73(1):65-70. PubMed ID: 15042650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women.
    Riva E; Serraino D; Pierangeli A; Bambacioni F; Zaniratti S; Minosse C; Selleri M; Bucci M; Scagnolari C; Degener AM; Capobianchi MR; Antonelli G; Dianzani F;
    Clin Microbiol Infect; 2007 Jan; 13(1):94-7. PubMed ID: 17184295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retrospective analysis of relationship between progression and regression of dysplasia and existence of HPV DNA by in situ hybridization].
    Ebisawa K; Shinozuka T; Kawai K; Fujii A; Kuroshima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Oct; 46(10):1041-8. PubMed ID: 7814934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.
    Schiffman M; Wheeler CM; Castle PE;
    J Infect Dis; 2002 Oct; 186(8):1169-72. PubMed ID: 12355370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
    Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
    J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls.
    Luxton JC; Rose RC; Coletart T; Wilson P; Shepherd PS
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():917-23. PubMed ID: 9129666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent detection of human papilloma viruses in cervical dysplasia by PCR single-strand DNA-conformational polymorphism analysis.
    Nakagawa H; Sugano K; Fujii T; Kubushiro K; Tsukazaki K; Nozawa S
    Anticancer Res; 2002; 22(3):1655-60. PubMed ID: 12168850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus: detection of viral DNA sequences and evidence for molecular heterogeneity in metaplasias and dysplasias of the uterine cervix.
    Lancaster WD; Kurman RJ; Sanz LE; Perry S; Jenson AB
    Intervirology; 1983; 20(4):202-12. PubMed ID: 6317605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus DNA after treatment of cervical dysplasia: low prevalence in normal cytologic smears.
    Bollen LJ; Tjong-A-Hung SP; van der Velden J; Mol BW; Lammes FB; ten Kate FW; ter Schegget J; Bleker OP
    Cancer; 1996 Jun; 77(12):2538-43. PubMed ID: 8640703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic features of cervical dysplasia associated with specific types of HPV DNA and cytologic features characteristic of HPV infection in dysplasia.
    Sato S; Maruta J; Ito K; Konno R; Yajima A; Sasaki H
    Acta Cytol; 1998; 42(6):1377-81. PubMed ID: 9850646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
    Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
    J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of various types of human papillomaviruses in premalignant and malignant cervical lesions using DNA-DNA in situ hybridization.
    Nimmanahaeminda K; Thamprasert K; Chantratita W
    J Med Assoc Thai; 1994 Mar; 77(3):120-5. PubMed ID: 7798845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions.
    Das BC; Sharma JK; Gopalakrishna V; Luthra UK
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2327-36. PubMed ID: 1328489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.